Greg has helped five private companies raise equity funds of $75+ million, obtained approval for an additional $230 million, and formed a joint venture with $300+ million in recurring revenues. With decades of experience in building teams, conducting valuation analysis, and in communicating with C-level executives and investors/partners, he now freelances to help companies properly position themselves for funding and operations expansion.
Created valuation analyses, industry reports, executive summaries, and investor decks that were instrumental in raising over $75 million for new ventures in biotech, commercial services, and consumer discretionary. Obtained approval for over $230 million in funding for international telecommunications (telecom) and alternative fuel ventures.
Developed business plans and acquisition analyses that supported the creation of an international joint venture and the approval of an international telecom project with over $250 million in recurring annual revenues.
Presented investor decks and communicated with investors and partners on behalf of client companies in biotech, agtech (agriculture tech), consumer discretionary, alternative fuels, telecom (domestic & international), energy, and institutional money management.
Directed the change in new venture's orientation to significantly expand addressable market and profitability while focusing on strengths and lowering capital requirements for B2B and B2C.
Incorporated multiple valuation analysis methodologies (DCF, comparable analysis, various metrics) to assess valuation at different timeframes; aligned with forecast and investor mindset.
Built financial models used to drive valuation and acquisition analyses, to assess capital requirements, and to assist in the business planning process.
Consulted on investment structures to balance needs of investors and corporate management.
Focus areas: Business Plan Development, Strategic Planning, Investor Decks, Investor Communications, Valuation Analysis, Executive Summaries
2007 - 2015
Millennium Asset Management
Achieved equity portfolio performance with an alpha of over 800 basis points on a compounded annual basis.
Made buy-and-sell investment decisions that were focused on fundamental forecasts and future valuation.
Communicated with CEOs and CFOs of companies regarding corporate strategy, vision, financials, operational performance, strengths, and weaknesses.
Communicated investment criteria and performance metrics to the marketing team and customers.
Focus areas: Fund Management, Investment Decision-making, Equity Valuation, Equity Research
Director of Research
2007 - 2013
Directed and managed a team of equity research analysts. Identified attractive companies for analysts to research and reviewed and approved all equity research reports.
Authored and published equity research on companies in biotech, healthcare, alternative fuels, consumer goods & services, energy, industrial, specialty chemicals, manufacturing, retail, technology, and pharmaceuticals.
Received many four- and five-star awards from StarMine for accuracy in earnings estimates.
Trained equity analysts in valuation analysis, business strategy assessment, and communications (written and oral) to improve their performance.
Communicated with institutional investor clients and with CEOs and CFOs of companies under coverage.
Focus areas: Equity Research, Equity Valuation, Valuation Modeling, Build Equity Research Team
Portfolio Manager | Director of Research
1988 - 2002
Noroian Capital Management
Achieved equity portfolio performance with an alpha of 430+ basis points on an annual compounded basis in an all-cap equity fund over ten years.
Established and directed the investment committee.
Created innovative cash flow analyses that tracked the change in cash flow returns on assets and investments. Integrated cash flow analyses into investment decision process and valuation analyses.
Developed an equity analyst team from scratch and selected companies for the analysts to research.
Integrated the skill sets of experienced money managers with those of young equity analysts.
Created corporate financial models designed to assess the future valuation and critical parameters for investment purposes.
Designed capital market equilibrium models to assess the general equity market under-valuation and/or over-valuation levels.
Focus areas: Investment Decision-making, Fund Management, Investment Portfolio Management, Equity Valuation, Build Equity Research Team
1983 - 1987
Standard & Poor's Compustat
Consulted with equity analysts and M&A analysts at Goldman Sachs, Salomon Brothers, Morgan Stanley, EF Hutton, Paine Weber, Aetna, and Travelers.
Consulted on competitive analyses and M&A with Xerox, General Electric, GTE Corp., Union Carbide, and Eaton.
Created innovative cash flow analyses before the cash flow was a reporting requirement.
Achieved an 98% revenue retention rate from the institutional investor clients.
Directed the integration of critical product features in the first PC-based institutional equity analysis product/services.